Allogeneic bone marrow transplantation compared with high-dose ARA-C post-remission therapy for acute myeloid leukemia

被引：0
|
作者：
Link, H
Ehninger, G
Hübner, G
Soucek, S
Schönrock-Nabulsi, P
Gramatzki, M
Franke, A
Einsele, H
Tischler, J
Brack, N
Otremba, B
Lutz, M
Gäckle, R
Öhl, S
Heidemann, E
Gieseler, F
Löffler, B
Weiss, J
Geer, T
Wandt, H
机构：
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
S6c
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Allogeneic bone marrow transplantation compared with high-dose Ara-C postremission therapy in acute myeloid leukemia
    Link, H
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 : S16 - S16
  • [2] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia
    Link, H
    Ehninger, G
    SchonrockNabulsi, P
    Gramatzki, M
    Daoud, A
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Gieseler, F
    Loffler, B
    Weiss, J
    Geer, T
    Wandt, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 840 - 840
  • [3] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia.
    Link, H
    Ehninger, G
    SchonrockNabulsi
    Gramatzki
    Franke, A
    Einsele, H
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Wilhelm, M
    Loffler, B
    Weiss, J
    Geer, T
    Diehl, S
    Wandt, H
    [J]. BLOOD, 1996, 88 (10) : 2723 - 2723
  • [4] A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
    Fukushima, Toshihiro
    Urasaki, Yoshimasa
    Yamaguchi, Masaki
    Ueda, Mikio
    Morinaga, Koji
    Haba, Toshihiro
    Sugiyama, Toshiro
    Nakao, Shinji
    Origasa, Hideki
    Umehara, Hisanori
    Ueda, Takanori
    [J]. ANTICANCER RESEARCH, 2012, 32 (02) : 643 - 647
  • [5] INTENSIVE POST-REMISSION THERAPY IN ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) USING VARIOUS DOSE SCHEDULES OF ARA-C
    MAYER, RJ
    [J]. BLUT, 1988, 57 (04): : 177 - 177
  • [6] Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia:: impact of induction Ara-C dose and post-remission therapy
    Sotomayor, EM
    Piantadosi, S
    Miller, CB
    Karp, JE
    Jones, RJ
    Rowley, SD
    Kaufmann, SH
    Braine, H
    Burke, PJ
    Gore, SD
    [J]. LEUKEMIA RESEARCH, 2002, 26 (05) : 461 - 471
  • [7] Post-remission therapy for acute myeloid leukemia
    Schlenk, Richard F.
    [J]. HAEMATOLOGICA, 2014, 99 (11) : 1663 - 1670
  • [8] Postremission therapy with one course of high-dose Ara-c for adult acute myeloid leukemia.
    Fagundes, EM
    Glória, ABF
    Viana, MB
    [J]. BLOOD, 1999, 94 (10) : 228B - 228B
  • [9] Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia
    Tsimberidou, AM
    Estey, E
    Cortes, JE
    Garcia-Manero, G
    Faderl, S
    Verstovsek, S
    Thomas, DA
    Ferrajoli, A
    Keating, MJ
    O'Brien, S
    Kantarjian, HM
    Giles, FJ
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (06) : 449 - 452
  • [10] Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia
    Apostolia M. Tsimberidou
    Elihu Estey
    Jorge E. Cortes
    Guillermo Garcia-Manero
    Stefan Faderl
    Srdan Verstovsek
    Deborah A. Thomas
    Alessandra Ferrajoli
    Michael J. Keating
    Susan O'Brien
    Hagop M. Kantarjian
    Francis J. Giles
    [J]. Cancer Chemotherapy and Pharmacology, 2003, 52 : 449 - 452
12345